By an immunohistochemical evaluation, a significantly lower AdipoR1/R2 expression in patients with gastric cancers was observed, as compared to patients with gastric intestinal metaplasia, suggesting that ADPN may have a role in gastric cancer progression as mediated by AdipoR1/R2 receptors. Here, ADIPOR1 is linked to gastric cancer.